Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi‐eligible countries

The nonavalent human papillomavirus (HPV) vaccine has generally been considered to confer enough additional benefit to warrant a higher price. However, most previous analyses did not fully consider p…

Read the full article here

Related Articles